161 related articles for article (PubMed ID: 25684974)
21. Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type.
Callejo SA; Dopierala J; Coupland SE; Damato B
Arch Ophthalmol; 2011 Jul; 129(7):958-60. PubMed ID: 21746991
[No Abstract] [Full Text] [Related]
22. Identification of candidate tumor oncogenes by integrative molecular analysis of choroidal melanoma fine-needle aspiration biopsy specimens.
McCannel TA; Burgess BL; Rao NP; Nelson SF; Straatsma BR
Arch Ophthalmol; 2010 Sep; 128(9):1170-7. PubMed ID: 20837802
[TBL] [Abstract][Full Text] [Related]
23. Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy.
Shields CL; Materin MA; Teixeira L; Mashayekhi A; Ganguly A; Shields JA
Ophthalmology; 2007 Oct; 114(10):1919-24. PubMed ID: 17698199
[TBL] [Abstract][Full Text] [Related]
24. [Cytogenetic analysis of choroidal melanoma].
Filloy A; Caminal JM; Varela MM; Gomà M; Arias L; Arruga J
Arch Soc Esp Oftalmol; 2014 Jan; 89(1):17-21. PubMed ID: 24269414
[TBL] [Abstract][Full Text] [Related]
25. Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy.
Marathe OS; Wu J; Lee SP; Yu F; Burgess BL; Leu M; Straatsma BR; McCannel TA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1046-8. PubMed ID: 20932685
[TBL] [Abstract][Full Text] [Related]
26. Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival.
Rodrigues M; Ait Rais K; Salviat F; Algret N; Simaga F; Barnhill R; Gardrat S; Servois V; Mariani P; Piperno-Neumann S; Roman-Roman S; Delattre O; Cassoux N; Savignoni A; Stern MH; Pierron G
JAMA Ophthalmol; 2020 Feb; 138(2):182-188. PubMed ID: 31895446
[TBL] [Abstract][Full Text] [Related]
27. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
[TBL] [Abstract][Full Text] [Related]
28. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
Lake SL; Coupland SE; Taktak AF; Damato BE
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
[TBL] [Abstract][Full Text] [Related]
29. Monosomy 3 predicts death but not time until death in choroidal melanoma.
Sandinha MT; Farquharson MA; McKay IC; Roberts F
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3497-501. PubMed ID: 16186325
[TBL] [Abstract][Full Text] [Related]
30. Artificial neural networks estimating survival probability after treatment of choroidal melanoma.
Damato B; Eleuteri A; Fisher AC; Coupland SE; Taktak AF
Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942
[TBL] [Abstract][Full Text] [Related]
31. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetics of uveal melanoma: a 7-year clinical experience.
Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
[TBL] [Abstract][Full Text] [Related]
33. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
34. Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma.
McCannel TA; Chang MY; Burgess BL
Ophthalmology; 2012 Mar; 119(3):606-10. PubMed ID: 22226884
[TBL] [Abstract][Full Text] [Related]
35. Detection of cryptic subtelomeric chromosome abnormalities and identification of anonymous chromatin using a quantitative multiplex ligation-dependent probe amplification (MLPA) assay.
Northrop EL; Ren H; Bruno DL; McGhie JD; Coffa J; Schouten J; Choo KH; Slater HR
Hum Mutat; 2005 Nov; 26(5):477-86. PubMed ID: 16170807
[TBL] [Abstract][Full Text] [Related]
36. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
[TBL] [Abstract][Full Text] [Related]
38. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
[TBL] [Abstract][Full Text] [Related]
39. Characterization of three cell lines derived from fine needle biopsy of choroidal melanoma with metastatic outcome.
Burgess BL; Rao NP; Eskin A; Nelson SF; McCannel TA
Mol Vis; 2011 Feb; 17():607-15. PubMed ID: 21386926
[TBL] [Abstract][Full Text] [Related]
40. Genomic profile of 320 uveal melanoma cases: chromosome 8p-loss and metastatic outcome.
Ewens KG; Kanetsky PA; Richards-Yutz J; Al-Dahmash S; De Luca MC; Bianciotto CG; Shields CL; Ganguly A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5721-9. PubMed ID: 23821189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]